Delivery Order SPE2DB22D3501-SPE2DB25FUJ59
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,911.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Entecavir 0.5 mg tablets in 30-count packages, with a completion date of May 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,173.12 Firm Fixed Price Delivery Order covers the supply of 4566684631 - Entecavir 1 mg Tablets in 30-count packages. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The federal contract award summarized is for the delivery of Entecavir 0.5 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp. This is a firm-fixed-price delivery order contract with a total ceiling value of $22,228.26 and a completion date of December 5, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,550.88 firm-fixed-price delivery order is for the supply of 4,566,616,046 units of the medication Entecavir 0.5 mg tablets, with a completion date of December 5, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,155.42 firm fixed-price delivery order contract is for the supply of Entecavir 0.5 mg tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $10,436.04 firm-fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets in 30-count packages. The contract has an ultimate completion date of October 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor, is for the delivery of Entecavir 0.5 mg tablets. The single award has a firm fixed price of $3,393.64 and a completion date of December 6, 2024. It was issued by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order, and there is no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This federal contract award is to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, to provide 4564728661 ENTECAVIR 0.5 MG TABLET 30S to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $3,334.76 and a completion date of May 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award is for the delivery of 4,560,847,525 units of the pharmaceutical product Entecavir 0.5 mg tablets, at a firm fixed price of $2,133.87. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of May 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...